TYCHE INDUSTRIES
|
TYCHE INDUSTRIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 11.95 | 13.83 | 9.11 | 19.51 | 17.14 |
| CEPS(Rs) | 13.84 | 15.56 | 10.85 | 21.19 | 18.84 |
| DPS(Rs) | 2.50 | 2.00 | 1.50 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 123.70 | 113.96 | 101.72 | 93.66 | 75.32 |
| Tax Rate(%) | 26.37 | 25.74 | 26.16 | 25.25 | 24.72 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 18.20 | 21.42 | 17.61 | 31.59 | 29.02 |
| EBIT Margin(%) | 23.93 | 25.32 | 20.30 | 34.18 | 31.65 |
| Pre Tax Margin(%) | 23.92 | 25.32 | 20.29 | 34.17 | 31.65 |
| PAT Margin (%) | 17.61 | 18.80 | 14.99 | 25.54 | 23.82 |
| Cash Profit Margin (%) | 20.41 | 21.15 | 17.86 | 27.74 | 26.18 |
| Performance Ratios | |||||
| ROA(%) | 8.69 | 10.84 | 7.87 | 18.88 | 20.82 |
| ROE(%) | 10.06 | 12.83 | 9.32 | 23.08 | 25.55 |
| ROCE(%) | 13.66 | 17.27 | 12.63 | 30.89 | 33.94 |
| Asset Turnover(x) | 0.49 | 0.58 | 0.52 | 0.74 | 0.87 |
| Sales/Fixed Asset(x) | 1.61 | 1.86 | 1.55 | 1.99 | 1.92 |
| Working Capital/Sales(x) | 0.65 | 0.79 | 0.71 | 1.00 | 1.22 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.62 | 0.54 | 0.64 | 0.50 | 0.52 |
| Receivable days | 108.17 | 93.20 | 98.34 | 70.11 | 57.20 |
| Inventory Days | 80.15 | 70.72 | 65.06 | 47.85 | 43.46 |
| Payable days | 101.61 | 99.08 | 84.32 | 95.07 | 85.34 |
| Valuation Parameters | |||||
| PER(x) | 14.70 | 10.09 | 15.17 | 8.74 | 4.37 |
| PCE(x) | 12.69 | 8.97 | 12.73 | 8.04 | 3.98 |
| Price/Book(x) | 1.42 | 1.23 | 1.36 | 1.82 | 0.99 |
| Yield(%) | 1.42 | 1.43 | 1.09 | 0.59 | 1.34 |
| EV/Net Sales(x) | 1.45 | 0.98 | 1.19 | 1.45 | 0.42 |
| EV/Core EBITDA(x) | 5.44 | 3.52 | 4.90 | 3.86 | 1.23 |
| EV/EBIT(x) | 6.08 | 3.86 | 5.86 | 4.25 | 1.32 |
| EV/CE(x) | 0.80 | 0.63 | 0.62 | 0.97 | 0.33 |
| M Cap / Sales | 2.59 | 1.90 | 2.27 | 2.23 | 1.04 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -7.79 | 21.07 | -20.42 | 6.16 | 36.62 |
| Core EBITDA Growth(%) | -11.47 | 38.75 | -48.67 | 17.50 | 114.41 |
| EBIT Growth(%) | -12.86 | 51.02 | -52.74 | 14.63 | 136.83 |
| PAT Growth(%) | -13.61 | 51.87 | -53.31 | 13.81 | 145.72 |
| EPS Growth(%) | -13.61 | 51.87 | -53.31 | 13.81 | 145.72 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 11.35 | 5.57 | 7.87 | 5.41 | 5.12 |
| Quick Ratio(x) | 10.13 | 4.71 | 7.00 | 4.80 | 4.47 |
| Interest Cover(x) | 8,315.30 | - | - | 3,613.84 | - |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of TYCHE INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TYCHE INDUSTRIES | ₹136.2 Cr | -0.3% | -5.5% | -24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
TYCHE INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TYCHE INDUSTRIES | -0.3% |
-5.5% |
-24.9% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses
